Tag: INTERMACS

21-HVI-2527704-CQD-Hero-2-650×450

PDE-5 Inhibitors May Benefit Patients After Centrifugal-Flow LVAD Implant

Outcome benefits from large registry lay groundwork for a randomized controlled trial

20-HVI-1925363-LVAD-650×450

Post-Implant PDE5 Inhibitor Therapy Lowers Thrombotic Events in LVAD Patients

INTERMACS analysis sets the stage for a confirmatory randomized trial

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad